乙肝大揭密专题知识.ppt

停止贺维力治疗以后，长期随访66例发生HBeAg血清转换的患者（中位数为55周），有91％的患者仍然维持HBeAg的血清转换 The 350 million chronic carriers of HBV worldwide, account for more than five per cent of the world’s population. Though widely distributed, hepatitis B prevalence varies from a highly endemic disease in China, Southeast Asia, and Africa to a disease of low endemicity in North America, Western Europe and Australia. In most developed countries, the prevalence of chronic HBV infection is 2%. Within these areas reside ethnic groups with HBV infection rates that are significantly higher than those of the general population e.g.